Moderate elevations of high-sensitivity cardiac troponin I and B-type natriuretic peptide in chronic hemodialysis patients are associated with mortality

Clinical Chemistry and Laboratory Medicine

Volumn 51, Issue 6, 2013, Pages 1321-1328

  Geerse, Daniël A ^a   Van Berkel, Miranda ^b   Vogels, Steffie ^a   Kooman, Jeroen P ^a   Konings, Constantijn J A M ^b   Scharnhorst, Volkher ^b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CATHARINA HOSPITAL   (Netherlands)

Author keywords

B type natriuretic peptide; Biomarker; Hemodialysis; Mortality; Troponin

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; TROPONIN I;

ADULT; AGED; ARTICLE; ASSAY; FEMALE; FOLLOW UP; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL;

AGED; C-REACTIVE PROTEIN; CHRONIC DISEASE; FEMALE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; RENAL DIALYSIS; TROPONIN I;

EID: 84882417667     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2012-0305     Document Type: Article

References (20)

1. Apple FS, Murakami MM, Pearce LA, Herzog CA. Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002;106:2941-5.
2. Khan NA, Hemmelgarn BR, Tonelli M, Thompson CR, Levin A. Prognostic value of troponin T and I among asymptomatic patients with end-stage renal disease: a meta-analysis. Circulation 2005;112:3088-96.
3. Satyan S, Light RP, Agarwal R. Relationships of N-terminal pro-B-natriuretic peptide and cardiac troponin T to left ventricular mass and function and mortality in asymptomatic hemodialysis patients. Am J Kidney Dis 2007;50:1009-19.
4. Hickman PE, McGill DA, Talaulikar G, Hiremagalur B, Bromley J, Rahman A, et al. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients. Intern Med J 2009;39:812-8.
5. Petrovic D, Obrenovic R, Stojimirovic B. Cardiac troponins and left ventricular hypertrophy in hemodialysis patients. Clin Lab 2008;54:145-52.
6. Sahinarslan A, Guz G, Okyay K, Mutluay R, Yalcin R, Bali M, et al. Prognostic value of troponin T and homocysteine in patients with end-stage renal disease. Turk Kardiyol Dern Ars 2008;36:382-7.
7. Wang AY, Lai KN. Use of cardiac biomarkers in end-stage renal disease. J Am Soc Nephrol 2008;19:1643-52.
8. Petrovic D, Stojimirovic BB. Cardiac troponins: outcome predictors in hemodialysis patients. J Artif Organs 2009;12:258-63.
9. Apple FS, Murakami MM, Pearce LA, Herzog CA. Multi-biomarker risk stratification of N-terminal pro-B-type natriuretic peptide, high-sensitivity C-reactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 2004;50:2279-85.
10. Jacobs LH, Van De Kerkhof J, Mingels AM, Kleijnen VW, Van Der Sande FM, Wodzig WK, et al. Haemodialysis patients longitudinally assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and cardiac troponin I assays. Ann Clin Biochem 2009;46:283-90.
11. Kumar N, Michelis MF, De Vita MV, Panagopoulos G, Rosenstock JL. Troponin I levels in asymptomatic patients on haemodialysis using a high-sensitivity assay. Nephrol Dial Transplant 2011;26:665-70.
12. Khan IA, Wattanasuwan N, Mehta NJ, Tun A, Singh N, Singh HK, et al. Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: a two-year outcome analysis. J Am Coll Cardiol 2001;38:991-8.
13. Van De Kerkhof D, Peters B, Scharnhorst V. Performance of the Advia Centaur second-generation troponin assay TnI-Ultra compared with the first-generation cTnI assay. Ann Clin Biochem 2008;45:316-7.
14. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
15. Madsen LH, Ladefoged S, Corell P, Schou M, Hildebrandt PR, Atar D. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int 2007;71:548-54.
16. Zoccali C, Mallamaci F, Benedetto FA, Tripepi G, Parlongo S, Cataliotti A, et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001;12:1508-15.
17. Jacobs LH, Van De Kerkhof JJ, Mingels AM, Passos VL, Kleijnen VW, Mazairac AH, et al. Inflammation, overhydration and cardiac biomarkers in haemodialysis patients: a longitudinal study. Nephrol Dial Transplant 2010;25:243-8.
18. Hallen J, Madsen L, Ladefoged S, Fagerland MW, Serebruany VL, Agewall S, et al. Incremental value of a combination of cardiac troponin T, N-terminal pro-brain natriuretic peptide and C-reactive protein for prediction of mortality in end-stage renal disease. Scand J Urol Nephrol 2011;45:151-8.
19. McGill D, Talaulikar G, Potter JM, Koerbin G, Hickman PE. Over time, high-sensitivity TnT replaces NT-proBNP as the most powerful predictor of death in patients with dialysis-dependent chronic renal failure. Clin Chim Acta 2010;411:936-9.
20. Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation 2003;107:363-9.